JAZZ
Jazz Pharmaceuticals
PEG ratio, current and historical analysis
- Stocks
- Healthcare
- NASDAQ: JAZZ
- PEG Ratio
Jazz Pharmaceuticals currently trades with a PE to growth ratio of 0.05, based on Sep 11, 2026 data. Dividing the 16.11 PE ratio by the 330.2% earnings growth rate produces this figure.
JAZZ PEG ratio history
Historically, Jazz Pharmaceuticals has a PEG ratio averaging 0.99 across the last ten years. At 0.05, today's PEG ratio sits 95% less than its historical average. The ten years high came in the Sep 2017 quarter at 5.9, reflecting peak valuation relative to growth. The bottom was reached in the Jun 2024 quarter at 0.03, suggesting attractive value relative to growth during that period.
Jazz Pharmaceuticals PEG ratio by year
| Year | PEG ratio | PE ratio | Growth YoY |
|---|---|---|---|
| 2025 | N/A | N/A | -164.5% |
| 2024 | 0.35 | 13.59 | 38.3% |
| 2023 | 0.07 | 18.78 | 283% |
| 2022 | N/A | N/A | 35.1% |
| 2021 | N/A | N/A | -229% |
| 2020 | N/A | 38.56 | -53.6% |
| 2019 | 0.68 | 16.19 | 23.8% |
| 2018 | N/A | 16.64 | -8.4% |
| 2017 | 0.69 | 16.56 | 23.9% |
| 2016 | 0.76 | 16.62 | 21.9% |
| 2015 | 0.06 | 26.13 | 449% |
| 2014 | N/A | 167.07 | -73.6% |
| 2013 | N/A | 34.11 | -27.1% |
| 2012 | 0.15 | 10.46 | 69.1% |
| 2011 | 0.05 | 12.83 | 234.4% |
Jazz Pharmaceuticals PEG ratio by quarter (TTM)
| Year | PEG ratio | PE ratio | Growth YoY |
|---|---|---|---|
| Jun 2026 | 0.05 | 15.79 | 330.2% |
| Mar 2026 | N/A | 402.23 | -94% |
| Dec 2025 | N/A | N/A | -164.5% |
| Sep 2025 | N/A | N/A | -180.4% |
| Jun 2025 | N/A | N/A | -205.6% |
| Mar 2025 | 0.33 | 15.94 | 48.9% |
| Dec 2024 | 0.35 | 13.59 | 38.3% |
| Sep 2024 | 0.03 | 14.95 | 520.8% |
| Jun 2024 | 0.03 | 17 | 536.1% |
| Mar 2024 | 0.07 | 23.02 | 308.4% |
| Dec 2023 | 0.07 | 18.78 | 283% |
| Sep 2023 | 0.19 | 107.87 | 561.5% |
| Jun 2023 | N/A | N/A | -77.8% |
| Mar 2023 | N/A | N/A | 66.4% |
| Dec 2022 | N/A | N/A | 35.1% |
JAZZ average PEG ratio chart
JAZZ's PEG ratio today is lower than the 3, 5 and 10-year averages.
PEG comparison
Jazz Pharmaceuticals's PEG of 0.05 is lower than the Healthcare sector and the industry average. Looking at the Healthcare sector average of 0.53, Jazz Pharmaceuticals's PEG is 91% lower.
JAZZ EPS growth
JAZZ Price vs fair value
JAZZ PEG vs peers
Relative to its peer stock TEVA, JAZZ's PEG ratio is lower.
Frequently asked questions
What is Jazz Pharmaceuticals's PEG ratio?
According to Sep 11, 2026 figures, JAZZ's PEG ratio stands at 0.05.
What is the 3-year average PEG ratio for Jazz Pharmaceuticals (JAZZ)?
Across the past 3 years, JAZZ's PEG ratio has averaged at 0.14.
What is the 5-year average PEG ratio for Jazz Pharmaceuticals (JAZZ)?
Across the past 5 years, JAZZ's PEG ratio has averaged at 0.14.
What is the highest PEG ratio for JAZZ?
JAZZ's PEG ratio topped out at 5.9 during the Sep 2017 quarter - the highest in ten years.
How does the current PEG ratio for JAZZ compare to its historical average?
Compared to the 10-year average, JAZZ's PEG ratio stands 95% lower.
Why is Jazz Pharmaceuticals's PEG ratio so low?
At 0.05, JAZZ's PEG ratio suggests the stock may be undervalued given its growth rate.
How is JAZZ's PEG ratio calculated (Jazz Pharmaceuticals PEG ratio formula)?
To calculate the PEG ratio, take the company's PE ratio and divide by its earnings per share growth (YoY TTM). As of Sep 11, 2026, Jazz Pharmaceuticals has a PE ratio of 16.11. Earnings grew at 330.2% over the TTM period ending Jun 2026. Applying the formula, this gives a PEG ratio of 0.05. PEG RATIO(0.05) = PE RATIO(16.11) / EPS GROWTH(330.2%)
All PEG ratio stats are based on quarterly TTM periods, unless otherwise specified.